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1  | INTRODUC TION
Cardiovascular diseases remain the leading cause of death in de-
veloped countries.1,2 In Portugal, cardiovascular diseases repre-
sent a major health problem, not only ischemic heart disease, but 
also stroke whose incidence in Portugal is among the highest in the 
world. According to National Statistics, although a 33% decrease 
has been observed since 1990, deaths due to cardiovascular dis-
eases still represented 29.7% of all deaths in 2015 in Portugal.3 
In other developed countries, the most common cardiovascular 
disease is ischemic heart disease, which accounts for more than 
20% of deaths in Europe.4 Clinically, the identification of patients 
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Background:	 Carotid	 intima-	media	 thickness	 (CIMT)	 is	 an	 established	 surrogate	
marker for cardiovascular events in patients with intermediate risk. In patients with 
high cardiovascular risk or established cardiovascular disease, the impact of CMIT 
measurement	on	risk	stratification	for	future	events	is	less	clear.	Our	objective	was	
to evaluate the impact of CIMT on the occurrence of cardiovascular events in a co-
hort of individuals with high cardiovascular risk, in long- term follow- up.
Methods: We analyzed 296 individuals, mean follow- up of 6.9 ± 2.2 years. Individuals 
were divided into tertiles according to CIMT. Tertiles were compared in terms of 
baseline characteristics and outcomes during follow- up—all- cause mortality and 
composite outcome (mortality, acute coronary syndromes, coronary revasculariza-
tion,	stroke/transient	ischemic	attack,	heart	failure,	or	cardiovascular	admission).
Results:	Our	population	had	a	mean	age	of	65	±	9	years	at	the	beginning	of	the	study,	
55% males. Patients with higher CIMT showed a trend for higher cardiovascular mor-
tality (P	=	0.084)	and	for	the	composite	outcome	(P	=	0.049).	A	CIMT	≥	0.85	mm	was	
also associated with higher rate of events; however, CIMT was not an independent 
predictor of outcome after adjustment for age and gender. CIMT assessment was 
useful in patients with hypertension, hyperlipidemia, and metabolic syndrome and in 
nondiabetic patients. For the composite outcome, it was also useful in females, smok-
ers, and in patients without coronary artery disease.
Conclusions: Patients with higher CIMT have worst outcome, but this was mainly 
driven by age and gender. CIMT is useful as a prognostic marker in specific subsets of 
patients.
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at risk of developing stroke and other cardiovascular events is of 
great significance, enabling preventive interventions and lifestyle 
modifications.	 Carotid	 intima-	media	 thickness	 (CIMT)	 has	 been	
suggested as a surrogate marker for coronary and peripheral ar-
tery disease. Being easily evaluated by a noninvasive test, it is 
recommended as “appropriate” in guidelines for cardiovascular 
risk stratification in the absence of known coronary artery dis-
ease for initial detection, particularly in patients at intermediate 
risk.5 In patients with high cardiovascular risk or with established 
cardiovascular disease, the role of CIMT is less well defined and 
guidelines consider its use as “inappropriate or unknown.” Few 
studies evaluated the prognostic value of CIMT in patients with 
established coronary artery disease and with conflicting results.6,7
In a previous study performed by our group, we sought to ana-
lyze the relationship between metabolic syndrome, coronary artery 
disease,	and	subclinical	carotid	atherosclerosis	(by	CIMT).8,9 At that 
time, we performed a cross- sectional analysis and included individu-
als were then prospectively followed for more than 5 years. Herein, 
we aimed to analyze the prognostic value of CIMT to predict fatal 
and nonfatal vascular events in long- term follow- up in the same high 
cardiovascular risk population of patients.
2  | POPUL ATION AND METHODS
The main study was an observational and cross- sectional study, with 
prospective inclusion of adult patients admitted for an elective coro-
nary angiography due to suspected coronary artery disease (with 
stable angina and/or with documented ischemia by noninvasive 
tests).8,9 Patients with previous acute coronary syndromes, myocar-
dial revascularization procedure, valvular heart disease, congenital 
heart disease, cardiomyopathy, or stroke/transient ischemic attack 
(TIA)	were	 excluded	 from	 the	 study.	 The	 local	 institutional	 ethics	
committee approved the study and all patients gave their written 
informed consent.
Blood pressure was measured on several occasions during 
hospital stay, and hypertension was defined by a previous diag-
nosis of hypertension or the presence of systolic blood pres-
sure	≥	140	mm	Hg	or	 diastolic	 blood	pressure	≥	90	mm	Hg	 (mean	
of	 two	 consecutive	measurements).	 Patients	 that	 smoked	during	
the previous 6 months were classified as smokers and were self- 
reported. Diabetes was recorded by the investigator based on 
patient	history,	increased	glucose	(fasting	level	≥	126	mg/dL),	a	gly-
cated hemoglobin > 6.5%, or concomitant use of specific therapy.
A venous blood sample was drawn after a 12- hour overnight 
fast. All the samples were analyzed in the hospital central labora-
tory. Blood glucose, total cholesterol, and triglycerides were de-
termined using automatic standard routine enzymatic methods. 
HDL- cholesterol was determined after specific precipitation. LDL- 
cholesterol was determined by Friedewald formula.
Coronary angiography was performed by the standard 
Judkins technique. The coronary angiograms were analyzed using 
QCA software and Cardiovascular Measurement System (QCA- 
CMS™)	 version	 6.0	 (Medis	 Medical	 Imaging	 Systems,	 Leiden,	 The	
Netherlands)	by	a	single	operator,	blinded	to	the	carotid	ultrasound	
results. Significant angiographic coronary artery disease was de-
fined by a stenosis of 70% or more in any coronary vessel (or 50% 
for	left	main	lesions).
Carotid intima- media thickness was evaluated by a trained radiol-
ogist	 (blinded	 for	 the	coronary	angiography	 result)	with	a	Siemens	
Sonolite™ system and a 7.5- MHz linear array transducer. High- 
resolution B- mode ultrasonography was used. In magnified and fro-
zen images, CIMT was measured at the distal common carotid artery 
(1	cm	proximal	to	the	carotid	bifurcation)	at	the	far	wall.	Manual	mea-
surements of CIMT were obtained from both the right side and the 
left side. The lumen/intima leading edge to media/adventitia leading 
edge method was used.10 CIMT value used for the present analysis 
was	defined	as	the	maximum	value	between	the	right	and	left	com-
mon carotids. The interclass correlation coefficients for intra- reader 
and inter- reader reproducibility were 0.907 and 0.820, respectively, 
which suggests good agreement beyond chance.8,9
Follow- up was obtained by telephone interview with the patient 
or with a close family member or by review of the medical records 
at 30 days, 1 year, and at least 5 years after inclusion in the study. 
A dedicated nursing team completed the follow- up. In the case of 
events during the follow- up period, patient’s medical records were 
thoroughly	 analyzed	 (if	 the	 events	 occurred	 in	 our	 hospital).	 For	
events in other hospitals, a contact was made with the attending 
physician of that institution to correctly adjudicate events.
Our	primary	outcome	was	all-	cause	mortality.	Other	secondary	
endpoints were also analyzed: cardiovascular mortality, acute cor-
onary	syndrome,	coronary	revascularization	after	the	index	admis-
sion, heart failure, stroke/TIA, or cardiovascular hospital admission. 
A composite outcome of all the mentioned outcomes was specifi-
cally analyzed.
2.1 | Statistical analysis
Statistical analysis was performed using the PASW 18.0 program 
(SPSS	 Inc,	Chicago,	 IL,	USA).	A	P- value < 0.05 was considered sta-
tistically significant.
Quantitative variables were described as mean and standard 
deviation, or as median and interquartile range for non- normally 
distributed variables. Normality was assessed with Kolmogorov–
Smirnov test. Qualitative variables are presented as percentages. 
ANOVA	 test	 or	 Kruskal–Wallis	 test	 was	 used	 for	 between-	group	
comparisons of continuous variables (according to distribution 
characteristics),	while	chi-	square	test	was	used	for	between-	group	
comparisons of categorical variables. Patients were grouped in ter-
tiles	of	CIMT.	Receiver	operator	characteristics	(ROC)	curve	analysis	
and	the	area	under	the	curve	(AUC)	were	used	as	a	measure	of	the	
predictive accuracy of CIMT on the considered outcomes. The best 
cutoff	of	CIMT	was	 selected	by	maximizing	 the	 sum	of	 sensitivity	
and specificity.
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Survival analysis with Kaplan–Meier curves and log- rank test 
was performed to analyze tertiles in each outcome considered. 
Cox-	proportional	 hazards	 models	 were	 built	 to	 assess	 the	 inde-
pendent predictive value of CIMT both in univariate and multi-
variate	models.	 Two	 risk	 prediction	models	 were	 considered:	 (a)	
adjusted	 for	 age	and	gender	 (known	predictors	of	CIMT);	 (b)	 ad-
justed for age, gender, and other significant predictors of outcome 
identified in univariate analysis. We also performed subgroup 
analysis to identify which specific subgroups might benefit of 
CIMT assessment.
3  | RESULTS
We included in the initial study 300 consecutive patients, who 
had been referred to our hospital from 2008 to 2010 for coronary 
Tertile 1 
IMT < 0.7 
n = 111
Tertile 2 
IMT 0.7–0.9 
n = 98
Tertile 3 
IMT ≥ 0.9 
n = 87
Total 
n = 296 P- value
Age	(years) 61 ± 10 66 ± 8 67 ± 8 65 ± 9 <0.001
Male	gender	(%) 37.8 57.1 73.6 54.7 <0.001
BMI (kg/m2) 28 ± 4 29 ± 5 28 ± 3 28 ± 4 0.413
MS	(%) 55.0 52.0 60.9 55.7 0.468
HTN	(%) 73.9 80.6 85.1 79.4 0.145
Smoking	(%) 5.4 9.2 13.8 9.1 0.126
Hyperlipidemia	(%) 77.5 65.3 65.5 69.9 0.090
Diabetes	(%) 15.3 25.5 25.3 21.6 0.124
Statins	(%) 56.8 60.2 64.4 60.1 0.555
CAD	(%) 27.0 44.9 56.3 41.6 <0.001
Total cholesterol 
(mg/dL)
186 ± 48 189 ± 46 181 ± 40 185 ± 44 0.405
LDL- cholesterol 
(mg/dL)
117 ± 37 119 ± 38 116 ± 30 117 ± 35 0.831
HDL- cholesterol 
(mg/dL)
46 ± 14 48 ± 12 41 ± 11 45 ± 13 0.002
Triglycerides (mg/
dL)
114 ± 86 114 ± 71 114 ± 62 114 ± 74 0.999
HbA1c	(%) 6.5 ± 0.9 6.9 ± 1.3 6.9 ± 1.5 6.7 ± 1.2 0.050
Creatinine	(mg/dL) 0.9 ± 0.3 0.9 ± 0.2 1.0 ± 0.3 0.9 ± 0.3 0.242
PCI	at	index	(%) 19.8 31.6 31.0 27.0 0.096
CABG	at	index	(%) 0.9 5.1 9.2 4.7 0.024
Revascularization at 
index	(%)
20.7 36.7 40.2 31.8 0.006
All- cause mortality 
(%)
5.4 13.3 12.6 10.1 0.112
Composite outcome 
(%)
14.4 25.5 27.6 22.0 0.049
Cardiovascular 
mortality	(%)
0.9 4.1 6.9 3.7 0.084
ACS	(%) 3.6 4.1 4.6 4.1 0.940
PCI	(%) 5.4 6.1 6.9 6.1 0.909
CABG	(%) 0 1.0 1.1 0.7 0.543
Stroke/TIA	(%) 1.8 1.0 4.6 2.4 0.247
Heart	failure	(%) 2.7 5.1 3.4 3.7 0.650
Cardiovascular 
admission	(%)
11.7 14.3 17.2 14.2 0.542
ACS	=	acute	coronary	syndrome;	BMI	=	body	mass	index;	CABG	=	coronary	artery	bypass	grafting;	
CAD = coronary artery disease; CIMT = carotid intima- media thickness; HTN = hypertension; 
MS = metabolic syndrome; PCI = percutaneous coronary intervention; TIA = transient ischemic 
attack.
TABLE  1 Baseline characteristics and 
outcome by CIMT tertiles
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angiography, aged 38–86 years. Four patients were lost during 
follow- up, and our final study sample included 296 patients. Mean 
age at entry was 65 ± 9 years, 55% males. Median follow- up was 
6.9 ± 2.2 years.
With increasing CIMT tertile, the prevalence of significant coro-
nary artery disease also increased, as well as the rate of revascular-
ization	at	 the	 index	hospitalization	 (Table	1).	The	 increase	 in	CIMT	
was associated with age and male gender, but not with other car-
diovascular risk factors. We found, however, some trend for rela-
tionship	with	hypertension,	smoking,	and	diabetes	and	a	paradoxical	
relationship with hyperlipidemia. HDL- cholesterol was lower in the 
group with the highest CIMT and there was a trend for higher HbA1c 
in both tertiles with CIMT > 0.7 mm.
Patients in the tertile of higher CIMT had a trend for more fre-
quent all- cause mortality (log- rank, P	=	0.105),	and	for	the	composite	
outcome (Log- rank, P	=	0.079),	particularly	cardiovascular	mortality	
and	 stroke/TIA	 (Table	1,	 Figure	1).	 CIMT	 had	 a	modest	 predictive	
accuracy for both all- cause mortality (AUC 0.643, 95% CI 0.543–
0.743)	and	for	the	composite	outcome	(AUC	0.611,	95%	CI	0.534–
0.688).	The	best	cutoff	of	CIMT	was	0.85	mm,	with	a	sensitivity	of	
70% and a specificity of 53% for all- cause mortality and a sensitivity 
of 66% and specificity of 55% for the composite outcome.
In univariate analysis, CIMT was a predictor of all- cause mortality 
as	a	continuous	variable	(Figure	2),	with	a	1.12	times	the	risk	for	each	
0.1 mm increase in thickness, and also with the cutoff of 0.85 mm, 
but	not	 after	 adjustment	 (Table	2).	 For	 the	 composite	outcome,	 in	
univariate analysis, it was also a predictor (both as categorical and 
continuous	distribution)	(Figure	2)	but	no	longer	after	adjustment	in	
multivariate	models	(Table	3).	The	other	independent	predictors	of	
outcome were diabetes and the presence of coronary artery disease 
that were included in model 2 for further adjustment.
In the subgroup analysis, CIMT assessment (with the cutoff of 
0.85	mm)	was	useful	to	assess	the	risk	of	all-	cause	mortality	in	pa-
tients with hypertension, hyperlipidemia, and metabolic syndrome 
and	in	nondiabetic	patients	(Figure	3).	For	the	composite	outcome,	
CIMT assessment was useful in females, patients with hypertension, 
hyperlipidemia, and metabolic syndrome, and also in non smokers, 
patients without diabetes, and patients without coronary artery dis-
ease	(Figure	4).
4  | DISCUSSION
The results presented herein confirmed the previously described as-
sociation	between	CIMT	and	age	(related	to	“vascular	age”)	as	well	
as with gender.8,9 CIMT is a predictor of outcome, but after adjust-
ment for other variables, particularly age and gender, this association 
is lost. However, with the use of a specific cutoff of 0.85 mm, the 
evaluation of CIMT might be useful in specific subsets of patients, 
both for all- cause mortality and for the composite outcome.
Previously published prospective studies on CIMT and cardio-
vascular disease risk demonstrated that CIMT was significantly as-
sociated with risk for myocardial infarction, stroke, coronary heart 
disease death, or a combination of these.7,8,11–19
The	CAFES-	CAVE	study	 in	healthy	 individuals	 showed	 that	 in-
creased wall thickness was associated with more vascular events 
(stroke	 and	 cardiovascular).12 The ARIC study with long- term fol-
low-	up	(4–7	years)	of	asymptomatic	individuals	showed	an	increased	
risk of coronary heart disease incidence and stroke, particularly in 
women.13,14 In the Cardiovascular Health Study (in patients older 
than	 65	years	 but	 without	 a	 history	 of	 cardiovascular	 admission),	
CIMT was directly associated with an increased risk of myocardial 
F IGURE  1 Kaplan–Meier	curves	for	all-	cause	mortality	(A)	and	composite	outcome	(B)	according	to	carotid	intima-	media	thickness	
tertiles
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infarction and stroke.15 The Rotterdam Study showed similar results, 
but a more modest risk.16 Additional adjustment for age and gender 
attenuated the association, particularly for coronary heart disease 
events and less for stroke. The major impact was only observed for 
higher	levels	of	CIMT,	especially	≥1	mm.	The	Carotid	Atherosclerosis	
Progression	Study	(CAPS)	showed	similar	results.18 Finally, a meta- 
analysis showed a hazard ratio for myocardial infarction adjusted for 
F IGURE  2 Hazard	ratios	(univariate)	for	all-	cause	mortality	(A)	and	composite	outcome	(B)	for	each	increase	in	carotid	intima-	media	
thickness
TABLE  2 Univariate and multivariate analysis for all- cause 
mortality
Hazard ratio 95% CI P- value
Univariate
Tertile 1 Reference – –
Tertile 2 2.59 0.98–6.82 0.054
Tertile 3 2.49 0.92–6.73 0.072
Continuous IMT 1.12 1.01–1.23 0.029
CIMT	≥	0.85	mm 2.56 1.17–5.59 0.018
Model 1
Tertile 1 Reference – –
Tertile 2 1.77 0.67–4.67 0.251
Tertile 3 1.38 0.50–3.81 0.528
Continuous IMT 1.07 0.95–1.20 0.250
CIMT	≥	0.85	mm 1.49 0.66–3.35 0.336
Model 2
Tertile 1 Reference – –
Tertile 2 1.51 0.56–4.04 0.416
Tertile 3 1.25 0.45–3.46 0.668
Continuous IMT 1.07 0.95–1.22 0.248
CIMT	≥	0.85	mm 1.35 0.58–3.14 0.481
Model 1: Adjusted for age and gender; model 2: adjusted for age, gender, 
coronary artery disease, and diabetes. Continuous IMT for each 0.1 mm 
increase.
CI = confidence interval; IMT = mean carotid intima- media thickness.
TABLE  3 Univariate and multivariate analysis for the composite 
outcome
Hazard ratio 95% CI P- value
Univariate
Tertile 1 Reference – –
Tertile 2 1.90 1.01–3.55 0.046
Tertile 3 2.06 1.09–3.87 0.026
Continuous IMT 1.09 1.01–1.17 0.022
CIMT	≥	0.85	mm 2.19 1.31–3.66 0.003
Model 1
Tertile 1 Reference – –
Tertile 2 1.43 0.75–2.70 0.272
Tertile 3 1.36 0.71–2.62 0.361
Continuous IMT 1.42 0.84–2.39 0.190
CIMT	≥	0.85	mm 1.52 0.88–2.62 0.131
Model 2
Tertile 1 Reference – –
Tertile 2 1.11 0.58–2.13 0.750
Tertile 3 0.99 0.50–1.94 0.972
Continuous IMT 1.02 0.94–1.11 0.622
CIMT	≥	0.85	mm 1.15 0.65–2.02 0.629
Model 1: Adjusted for age and gender; model 2: adjusted for age, gender, 
and diabetes. Continuous IMT for each 0.1 mm increase.
CI = confidence interval; IMT = mean carotid intima- media thickness.
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age	and	gender	of	1.26	(1.21–1.30)	and	1.32	(1.27–1.38)	for	stroke	
for each 0.1 mm increase in CIMT.19
More recent studies showed different results. Both the Tromso 
study	and	the	Multi-	Ethnic	Study	of	Atherosclerosis	(MESA)	showed	
that common CIMT is associated with incident stroke in unadjusted 
analysis, but this association became nonsignificant after adjustment 
for several risk factors.20,21 In the MESA study, measurements of 
CMIT	were	made	 in	 a	more	 proximal	 part	 of	 the	 common	 carotid	
and more distant to the carotid bulb.20 In the Tromso study, mea-
surements that included the carotid bifurcation were associated 
with stroke.21 These discrepancies confirm the importance of site 
measurement.
Carotid intima- media thickness value also provides additional 
information beyond traditional risk factors for classifying patients 
in regard to the likelihood of the presence of significant angio-
graphic coronary artery disease.22 These findings provide support 
to the concept that CIMT measurements can be used as a sur-
rogate marker of atherosclerosis. A report from the ARIC study 
demonstrated the ability of carotid ultrasound data to improve 
coronary heart disease risk prediction.22 Thus, ultrasound- based 
CIMT measurement and identification of plaque presence improve 
coronary heart disease risk prediction and should be considered 
in the intermediate- risk group. However, intima- media thickening 
is a feature of arterial wall aging, and carotid wall thickening is 
not synonymous of atherosclerosis, particularly in the absence of 
plaques.	It	represents	the	pathophysiologic	substrate	that	explains	
why	CIMT	is	a	risk	factor	and	a	marker	of	cardiovascular	risk.	Our	
previous work showed that age is one of the main independent 
predictors of CIMT.8,9
Fewer studies addressed the prognostic impact of CIMT in 
patients with established coronary artery disease or high car-
diovascular risk and thus recommendations for this population 
about the use of CIMT study is not well established. The Angina 
Prognosis	Study	in	Stockholm	(APSIS)	study	in	patients	with	sta-
ble angina showed that CIMT is a weak predictor of events, with 
carotid plaques being highly predictive.6 However, median fol-
low- up was only of 3 years. Another study in patients with non- 
ST- acute coronary syndromes showed that CIMT was correlated 
with TIMI risk score but it did not predict 6- month clinical out-
come.7 This correlation with TIMI risk score was mainly driven 
by the association demonstrated of CIMT with age and diabetes, 
main components of TIMI risk score. These results are in line with 
our own results.
Surprisingly, we found no association between CIMT and both 
total cholesterol and LDL- cholesterol. The same was previously re-
ported in the ISMIR study.23 In that study, in the metabolic syndrome 
population, only triglycerides remained significantly associated with 
CIMT value, while total cholesterol and non- HDL- cholesterol failed 
F IGURE  3 Subgroup	analysis	of	carotid	intima-	media	thickness	≥	0.85	mm	for	all-	cause	mortality
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to	reach	a	significant	correlation.	The	author’s	explanation	was	that	
statin treatment, present in almost half of the subgroups, could alter 
the typical lipid profile of these patients, particularly regarding cho-
lesterol levels, and can thus modify the relationship between plasma 
cholesterol	and	CIMT.	Our	patients	also	had	a	very	high	rate	of	sta-
tin	therapy,	and	lipid	profile	was	better	than	expected,	which	might	
have influenced our results. In fact, only HDL- cholesterol showed 
some inverse relationship with CIMT.
Carotid intima- media thickness has a relatively low sensitivity 
and specificity for the prediction of cardiovascular outcomes, and 
after adjustment for other independent predictors, it is no longer 
an independent predictor. However, we observed that in specific 
subsets of patients it might be useful for the prediction of all- cause 
mortality, particularly in patients with hypertension, hyperlipidemia, 
and metabolic syndrome and in nondiabetic patients, and also in fe-
males, nonsmokers, and patients without coronary artery disease 
for	the	composite	outcome.	This	is	easily	explained	by	the	fact	that	
older age and male gender are closely associated with increases in 
CIMT and cardiovascular events, and thus, it does not add signifi-
cant prognostic information. The same is true for diabetes, smoking, 
and coronary artery disease, all of which are known predictors of 
cardiovascular events and the benefit of CIMT assessment is less 
important for risk assessment.
4.1 | Limitations
The scanning protocol for CIMT measurement only focused on the 
common carotid artery due to difficulties in adequate evaluation 
of CIMT within the bulb and internal carotid arteries. Scanning of 
the remaining segments of the carotid arteries might be important 
to avoid missing “upstream” advanced atherosclerosis. The site of 
measurement has important implications as already mentioned but 
we used the recommended technique.
Manual assessment of CIMT is not optimally reproducible. There 
have been rapid advances in ultrasound technology resulting in 
greater consistency and resolution of images. Semi- automated edge- 
detection software to measure CIMT has been developed and has 
been found to be both accurate and reproducible. At the time of data 
collection, we did not have the automated software, but our repro-
ducibility	analysis	is	quite	good,	better	than	what	was	reported	by	Van	
der Meer.17 Automated technology might have yield different results.
Angiographic study does not assess directly coronary plaque 
morphology. Intravascular ultrasound allows cross- sectional imaging 
of coronary arteries and provides more comprehensive assessment 
of atherosclerotic plaque in vivo and this is considered the gold stan-
dard technique. For that reason, quantitative coronary angiography 
analysis might be slightly misleading.
F IGURE  4 Subgroup	analysis	of	carotid	intima-	media	thickness	≥	0.85	mm	for	the	composite	outcome
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The sample size is somewhat small but we considered that the 
original population was an important group and decided to perform 
long- term follow- up in this cohort of patients. A study in a larger 
sample is advisable to confirm our results. It would also have been in-
teresting to include a low- risk group for comparison, but the original 
work was focused in patients with high cardiovascular risk and thus 
we do not have a population of patients with low cardiovascular risk, 
CIMT assessment, and such a long- term follow- up for comparison.
5 | CONCLUSIONS
Patients with higher CIMT have worst long- term outcome both for 
fatal and nonfatal cerebral and cardiovascular events. However, this 
is mainly driven by age and gender. Measurements of CIMT might 
be useful in specific subsets of patients, particularly in patients 
with hypertension, hyperlipidemia, and metabolic syndrome and in 
nondiabetic patients.
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